{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:18:24Z","timestamp":1776125904022,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"KAMADA, LTD"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.cellimm.2020.104177","type":"journal-article","created":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T11:16:43Z","timestamp":1595589403000},"page":"104177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Distinct anti-inflammatory properties of alpha1-antitrypsin and corticosteroids reveal unique underlying mechanisms of action"],"prefix":"10.1016","volume":"356","author":[{"given":"Ronen","family":"Schuster","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noa","family":"Motola-Kalay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris M.","family":"Baranovski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliana","family":"Bar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveh","family":"Tov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Stein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eli C.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8304-1320","authenticated-orcid":false,"given":"Michal","family":"Ayalon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuval","family":"Sagiv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cellimm.2020.104177_b0005","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00171-2018","article-title":"Diagnosis and management of alpha1-antitrypsin deficiency in Europe: an expert survey","volume":"5","author":"Horvath","year":"2019","journal-title":"ERJ Open Res."},{"issue":"8","key":"10.1016\/j.cellimm.2020.104177_b0010","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.rmed.2011.02.002","article-title":"The discovery of alpha1-antitrypsin and its role in health and disease","volume":"105","author":"Janciauskiene","year":"2011","journal-title":"Respir Med."},{"issue":"12","key":"10.1016\/j.cellimm.2020.104177_b0015","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1172\/JCI41196","article-title":"alpha-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8","volume":"120","author":"Bergin","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.cellimm.2020.104177_b0020","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/FJC.0000000000000250","article-title":"Cytoprotective Role of Alpha-1 Antitrypsin in Vascular Endothelial Cell Under Hypoxia\/Reoxygenation Condition","volume":"66","author":"Feng","year":"2015","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"Suppl 2","key":"10.1016\/j.cellimm.2020.104177_b0025","first-page":"S146","article-title":"Alpha-1 Antitrypsin and Lung Cell Apoptosis","volume":"13","author":"Serban","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"7","key":"10.1016\/j.cellimm.2020.104177_b0030","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.4049\/jimmunol.159.7.3555","article-title":"Alpha 1-acid glycoprotein and alpha 1-antitrypsin inhibit TNF-induced but not anti-Fas-induced apoptosis of hepatocytes in mice","volume":"159","author":"Van Molle","year":"1997","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.cellimm.2020.104177_b0035","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.2337\/db06-1273","article-title":"Alpha1-antitrypsin protects beta-cells from apoptosis","volume":"56","author":"Zhang","year":"2007","journal-title":"Diabetes."},{"issue":"2","key":"10.1016\/j.cellimm.2020.104177_b0040","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1073\/pnas.1117665109","article-title":"Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation","volume":"109","author":"Tawara","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"issue":"3","key":"10.1016\/j.cellimm.2020.104177_b0045","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/imm.12149","article-title":"Human alpha1-antitrypsin modifies B-lymphocyte responses during allograft transplantation","volume":"140","author":"Mizrahi","year":"2013","journal-title":"Immunology."},{"issue":"42","key":"10.1016\/j.cellimm.2020.104177_b0050","doi-asserted-by":"crossref","first-page":"16236","DOI":"10.1073\/pnas.0807627105","article-title":"alpha1-Antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice","volume":"105","author":"Lewis","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.cellimm.2020.104177_b0055","first-page":"267","article-title":"Alpha-1 Antitrypsin Substitution for Extrapulmonary Conditions in Alpha-1 Antitrypsin Deficient Patients","volume":"5","author":"Baranovski","year":"2018","journal-title":"Chronic Obstr. Pulm Dis."},{"issue":"1","key":"10.1016\/j.cellimm.2020.104177_b0060","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/FJC.0000000000000383","article-title":"Recombinant Human Alpha-1 Antitrypsin-Fc Fusion Protein Reduces Mouse Myocardial Inflammatory Injury After Ischemia-Reperfusion Independent of Elastase Inhibition","volume":"68","author":"Toldo","year":"2016","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"12","key":"10.1016\/j.cellimm.2020.104177_b0065","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1074\/jbc.M607976200","article-title":"Alpha1-antitrypsin, old dog, new tricks. Alpha1-antitrypsin exerts in vitro anti-inflammatory activity in human monocytes by elevating cAMP","volume":"282","author":"Janciauskiene","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2020.104177_b0070","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3389\/fimmu.2013.00320","article-title":"Human \u03b11-Antitrypsin Binds to Heat-Shock Protein gp96 and Protects from Endogenous gp96-Mediated Injury In vivo","volume":"4","author":"Ochayon","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2020.104177_b0075","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2119\/molmed.2011.00196","article-title":"Expanding the clinical indications for alpha(1)-antitrypsin therapy","volume":"18","author":"Lewis","year":"2012","journal-title":"Mol. Med."},{"key":"10.1016\/j.cellimm.2020.104177_b0080","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1479-5876-9-21","article-title":"Alpha-1 antitrypsin protein and gene therapies decrease autoimmunity and delay arthritis development in mouse model","volume":"9","author":"Grimstein","year":"2011","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.cellimm.2020.104177_b0085","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11011-011-9239-9","article-title":"Sustained expression of circulating human alpha-1 antitrypsin reduces inflammation, increases CD4+FoxP3+ Treg cell population and prevents signs of experimental autoimmune encephalomyelitis in mice","volume":"26","author":"Subramanian","year":"2011","journal-title":"Metab Brain Dis."},{"issue":"2","key":"10.1016\/j.cellimm.2020.104177_b0090","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.transproceed.2008.02.010","article-title":"Alpha-1 antitrypsin treatment of spontaneously diabetic nonobese diabetic mice receiving islet allografts","volume":"40","author":"Pileggi","year":"2008","journal-title":"Transplant. Proc."},{"issue":"5","key":"10.1016\/j.cellimm.2020.104177_b0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063625","article-title":"Pancreatic islet xenograft survival in mice is extended by a combination of alpha-1-antitrypsin and single-dose anti-CD4\/CD8 therapy","volume":"8","author":"Ashkenazi","year":"2013","journal-title":"PLoS One."},{"issue":"9","key":"10.1016\/j.cellimm.2020.104177_b0100","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.bbmt.2016.05.011","article-title":"Response of Steroid-Refractory Acute GVHD to alpha1-Antitrypsin","volume":"22","author":"Marcondes","year":"2016","journal-title":"Biol. Blood Marrow Trans."},{"issue":"18","key":"10.1016\/j.cellimm.2020.104177_b0105","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1182\/blood-2014-04-570440","article-title":"alpha-1-Antitrypsin (AAT)-modified donor cells suppress GVHD but enhance the GVL effect: a role for mitochondrial bioenergetics","volume":"124","author":"Marcondes","year":"2014","journal-title":"Blood."},{"issue":"12","key":"10.1016\/j.cellimm.2020.104177_b0110","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1182\/blood-2017-11-815746","article-title":"alpha1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease","volume":"131","author":"Magenau","year":"2018","journal-title":"Blood."},{"key":"10.1016\/j.cellimm.2020.104177_b0115","doi-asserted-by":"crossref","unstructured":"Thangavelu G, Blazar BR. Achievement of Tolerance Induction to Prevent Acute Graft-vs.-Host Disease. Front Immunol. 2019;10:309.","DOI":"10.3389\/fimmu.2019.00309"},{"issue":"5","key":"10.1016\/j.cellimm.2020.104177_b0120","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1084\/jem.178.5.1629","article-title":"Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells","volume":"178","author":"Tilg","year":"1993","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.cellimm.2020.104177_b0125","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.biocel.2007.02.017","article-title":"alpha1-Antitrypsin regulates CD14 expression and soluble CD14 levels in human monocytes in vitro","volume":"39","author":"Nita","year":"2007","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"10.1016\/j.cellimm.2020.104177_b0130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1465-9921-6-12","article-title":"Prolastin, a pharmaceutical preparation of purified human alpha1-antitrypsin, blocks endotoxin-mediated cytokine release","volume":"6","author":"Nita","year":"2005","journal-title":"Respir. Res."},{"issue":"1","key":"10.1016\/j.cellimm.2020.104177_b0135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0014-5793(92)80156-B","article-title":"Inhibition of neutrophil superoxide production by human plasma alpha 1-antitrypsin","volume":"300","author":"Bucurenci","year":"1992","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cellimm.2020.104177_b0140","doi-asserted-by":"crossref","unstructured":"Bergin DA, Reeves EP, Hurley K, Wolfe R, Jameel R, Fitzgerald S, et al. The circulating proteinase inhibitor alpha-1 antitrypsin regulates neutrophil degranulation and autoimmunity. Sci Transl Med. 2014;6(217):217ra1.","DOI":"10.1126\/scitranslmed.3007116"},{"key":"10.1016\/j.cellimm.2020.104177_b0145","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.virol.2018.07.014","article-title":"Toll-like receptor agonist R848 blocks Zika virus replication by inducing the antiviral protein viperin","volume":"522","author":"Vanwalscappel","year":"2018","journal-title":"Virology."},{"issue":"6","key":"10.1016\/j.cellimm.2020.104177_b0150","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/annrheumdis-2014-206966","article-title":"Alpha-1-anti-trypsin-Fc fusion protein ameliorates gouty arthritis by reducing release and extracellular processing of IL-1beta and by the induction of endogenous IL-1Ra","volume":"75","author":"Joosten","year":"2016","journal-title":"Ann. Rheum Dis."},{"issue":"4","key":"10.1016\/j.cellimm.2020.104177_b0155","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/cmi.2014.17","article-title":"alpha1-antitrypsin increases interleukin-1 receptor antagonist production during pancreatic islet graft transplantation","volume":"11","author":"Abecassis","year":"2014","journal-title":"Cell Mol. Immunol."},{"issue":"11","key":"10.1016\/j.cellimm.2020.104177_b0160","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.3727\/096368912X657701","article-title":"Revascularization of pancreatic islet allografts is enhanced by alpha-1-antitrypsin under anti-inflammatory conditions","volume":"22","author":"Bellacen","year":"2013","journal-title":"Cell Trans."},{"issue":"3","key":"10.1016\/j.cellimm.2020.104177_b0165","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.amjsurg.2012.11.018","article-title":"Corticosteroids and wound healing: clinical considerations in the perioperative period","volume":"206","author":"Wang","year":"2013","journal-title":"Am. J. Surg."},{"issue":"9","key":"10.1016\/j.cellimm.2020.104177_b0170","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/003655201750305495","article-title":"Corticosteroids impair intestinal epithelial wound repair mechanisms in vitro","volume":"36","author":"Jung","year":"2001","journal-title":"Scand. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.cellimm.2020.104177_b0175","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00011-007-6115-5","article-title":"Optimized THP-1 differentiation is required for the detection of responses to weak stimuli","volume":"56","author":"Park","year":"2007","journal-title":"Inflamm. Res."},{"issue":"12","key":"10.1016\/j.cellimm.2020.104177_b0180","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.5665\/sleep.3236","article-title":"A pro-inflammatory role for nuclear factor kappa B in childhood obstructive sleep apnea syndrome","volume":"36","author":"Israel","year":"2013","journal-title":"Sleep."},{"issue":"5","key":"10.1016\/j.cellimm.2020.104177_b0185","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1189\/jlb.0208145","article-title":"Alpha-1-antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood","volume":"85","author":"Pott","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cellimm.2020.104177_b0190","doi-asserted-by":"crossref","unstructured":"Efficacy of In Vivo Electroporation-Mediated IL-10 Gene Delivery on Survival of Skin Flaps. Journal of Membrane Biology. 2018;251(2):211--9.","DOI":"10.1007\/s00232-017-9974-x"},{"key":"10.1016\/j.cellimm.2020.104177_b0195","doi-asserted-by":"crossref","unstructured":"Ishida YaKTaKAaMKaMN. Absence of IL-1 Receptor Antagonist Impaired Wound Healing along with Aberrant NF-B Activation and a Reciprocal Suppression of TGF- Signal Pathway. The Journal of Immunology. 2006;176(9):5598--606.","DOI":"10.4049\/jimmunol.176.9.5598"},{"issue":"11","key":"10.1016\/j.cellimm.2020.104177_b0200","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.vaccine.2018.01.077","article-title":"Routing dependent immune responses after experimental R848-adjuvated vaccination","volume":"36","author":"van Aalst","year":"2018","journal-title":"Vaccine."},{"key":"10.1016\/j.cellimm.2020.104177_b0205","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3389\/fimmu.2016.00559","article-title":"Context-Specific and Immune Cell-Dependent Antitumor Activities of alpha1-Antitrypsin","volume":"7","author":"Guttman","year":"2016","journal-title":"Front Immunol."},{"key":"10.1016\/j.cellimm.2020.104177_b0210","doi-asserted-by":"crossref","unstructured":"Ruffilli I, Ferrari SM, Colaci M, Ferri C, Fallahi P, Antonelli A. IP-10 in autoimmune thyroiditis. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. 2014;46(9):597-602.","DOI":"10.1055\/s-0034-1382053"},{"issue":"9","key":"10.1016\/j.cellimm.2020.104177_b0215","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1128\/IAI.69.9.5249-5263.2001","article-title":"Cellular mechanisms that cause suppressed gamma interferon secretion in endotoxin-tolerant mice","volume":"69","author":"Varma","year":"2001","journal-title":"Infect Immun."},{"issue":"8","key":"10.1016\/j.cellimm.2020.104177_b0220","doi-asserted-by":"crossref","first-page":"E1418","DOI":"10.1210\/jc.2013-3864","article-title":"alpha1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1beta responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes","volume":"99","author":"Gottlieb","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.cellimm.2020.104177_b0225","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.leukres.2004.05.009","article-title":"Normal neutrophil maturation is associated with selective loss of MAP kinase activation by G-CSF","volume":"29","author":"Baumann","year":"2005","journal-title":"Leuk. Res."},{"key":"10.1016\/j.cellimm.2020.104177_b0230","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2147\/JIR.S156405","article-title":"The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals","volume":"11","author":"Dunlea","year":"2018","journal-title":"J. Inflamm. Res."},{"issue":"Suppl 4","key":"10.1016\/j.cellimm.2020.104177_b0235","doi-asserted-by":"crossref","first-page":"S297","DOI":"10.1513\/AnnalsATS.201509-634KV","article-title":"The Role of Neutrophils in Alpha-1 Antitrypsin Deficiency","volume":"13","author":"McCarthy","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"Suppl 2","key":"10.1016\/j.cellimm.2020.104177_b0240","doi-asserted-by":"crossref","first-page":"S342","DOI":"10.1086\/513857","article-title":"Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients","volume":"179","author":"Root","year":"1999","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.cellimm.2020.104177_b0245","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1164\/rccm.200204-298OC","article-title":"Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease","volume":"167","author":"Culpitt","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.cellimm.2020.104177_b0250","doi-asserted-by":"crossref","DOI":"10.1111\/aji.12741","article-title":"Cortisol inhibits CSF2 and CSF3 via DNA methylation and inhibits invasion in first-trimester trophoblast cells","volume":"78","author":"Smith","year":"2017","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.cellimm.2020.104177_b0255","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3389\/fimmu.2019.00590","article-title":"S-Nitrosylation of alpha1-Antitrypsin Triggers Macrophages Toward Inflammatory Phenotype and Enhances Intra-Cellular Bacteria Elimination","volume":"10","author":"Kaner","year":"2019","journal-title":"Front Immunol."},{"issue":"9","key":"10.1016\/j.cellimm.2020.104177_b0260","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/infdis\/jiu620","article-title":"Acute phase protein alpha1-antitrypsin reduces the bacterial burden in mice by selective modulation of innate cell responses","volume":"211","author":"Kaner","year":"2015","journal-title":"J Infect Dis."},{"issue":"23","key":"10.1016\/j.cellimm.2020.104177_b0265","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20236032","article-title":"A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Alpha-1 Antitrypsin (AAT) (Glassia((R))) in the Treatment of Recent-Onset Type 1 Diabetes","volume":"20","author":"Lebenthal","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.cellimm.2020.104177_b0270","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.otc.2010.04.003","article-title":"A comprehensive review of the adverse effects of systemic corticosteroids","volume":"43","author":"Poetker","year":"2010","journal-title":"Otolaryngol. Clin. North. Am."},{"key":"10.1016\/j.cellimm.2020.104177_b0275","doi-asserted-by":"crossref","unstructured":"Youssef J, Novosad SA, Winthrop KL. Infection Risk and Safety of Corticosteroid Use. Rheum Dis Clin North Am. 2016;42(1):157-76, ix-x.","DOI":"10.1016\/j.rdc.2015.08.004"},{"issue":"8","key":"10.1016\/j.cellimm.2020.104177_b0280","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.4049\/jimmunol.153.8.3584","article-title":"LPS-induced expression of the human IL-1 receptor antagonist gene is controlled by multiple interacting promoter elements","volume":"153","author":"Smith","year":"1994","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.cellimm.2020.104177_b0285","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.4049\/jimmunol.164.4.1940","article-title":"A prominent role for Sp1 during lipopolysaccharide-mediated induction of the IL-10 promoter in macrophages","volume":"164","author":"Brightbill","year":"2000","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.cellimm.2020.104177_b0290","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1089\/wound.2018.0889","article-title":"Enhanced Survival and Accelerated Perfusion of Skin Flap to Recipient Site Following Administration of Human alpha1-Antitrypsin in Murine Models","volume":"8","author":"Schuster","year":"2019","journal-title":"Adv. Wound Care (New Rochelle)."}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874920303373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874920303373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T18:22:26Z","timestamp":1762107746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874920303373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":58,"alternative-id":["S0008874920303373"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2020.104177","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinct anti-inflammatory properties of alpha1-antitrypsin and corticosteroids reveal unique underlying mechanisms of action","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2020.104177","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104177"}}